Pharmacotherapy and the risk for community-acquired pneumonia
<p>Abstract</p> <p>Background</p> <p>Some forms of pharmacotherapy are shown to increase the risk of community-acquired pneumonia (CAP). The purpose of this study is to investigate whether pharmacotherapy with proton pump inhibitors (PPI), inhaled corticosteroids, and a...
Main Authors: | Mody Lona, Heh Victor, Khan Salman, Acharya Utkarsh, Gau Jen-Tzer, Kao Tzu-Cheg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Geriatrics |
Online Access: | http://www.biomedcentral.com/1471-2318/10/45 |
Similar Items
-
Risk factors associated with lower defecation frequency in hospitalized older adults: a case control study
by: Gau, Jen-Tzer, et al.
Published: (2015) -
Modern approaches to pharmacotherapy of Community-Acquired Pneumonia
by: Anna A. Gavrilova, et al.
Published: (2020-12-01) -
Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis
by: I. A. Narkevich, et al.
Published: (2019-01-01) -
Pharmacoeconomic research of pharmacotherapy schemes of community-acquired pneumonia with the inclusion of antiviral drugs
by: S. O. Soloviov, et al.
Published: (2020-03-01) -
Rational strategy of pharmacotherapy of patients with community-acquired pneumonia at elderly and senil eage
by: L. F. Kuznetsova, et al.
Published: (2014-04-01)